Who owns AVENUE THERAPEUTICS INC?
- Ticker: ATXI
- CUSIP Number: 05360l403
Tip: Access positions for across all investors
Analyze quarterly positions in Avenue Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avenue Therapeutics stock
Who bought or sold AVENUE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 115k | $286k | 53% | Sep 2024 |
|
| Sabby Management | 63k | $157k | 69% | Sep 2024 |
|
| UBS Group | 6.1k | $15k | 813% | Sep 2024 |
|
| Tower Research Capital | 1.7k | $4.3k | -46% | Sep 2024 |
|
| Wells Fargo & Company | 561.00 | $1.4k | 820% | Sep 2024 |
|
| Bank of America Corporation | 10.00 | $25.000000 | 43% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $3.000000 | 0% | Sep 2024 |
|
Who sold out of Avenue Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Moss Adams Wealth Advisors | Sep 2024 | 11k | $27k |
| Royal Bank of Canada | Jun 2024 | 8.00 | $0 |